The use of Erlangen diamidine 98/202 in relapsing Trypanosoma brucei infections in mice
- 1 January 1982
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 76 (2) , 204-207
- https://doi.org/10.1016/0035-9203(82)90275-9
Abstract
Mice infected with T. brucei GVR 23/1 or T. brucei GVR 35/1 for 21 days were treated with the Erlangen diamidine 98/202 (6-amidino-2-[4' amidino-phenyl] thionaphthene-dilacate) at either 5 mg/kg or 35 mg/kg. At both these dose levels the parasites were initially cleared from the circulation although the infections eventually relapsed due to reinvasion from the central nervous system. If the 98/202 therapy is followed by treatment with 5-nitroimidazole only a small number of mice are permanently cured. Adverse reactions, especially at the 35 mg/kg dose level, were noted in one experiment. The Erlangen diamidine given to infected mice three days after infection was able to permanently cure both Trypanosoma brucei stabilates.Keywords
This publication has 4 references indexed in Scilit:
- ‘Berenil’ and nitroimidazole combinations in the treatment of Trypanosoma brucei infection with central nervous system involvementInternational Journal for Parasitology, 1980
- The relationship between duration of infection with Trypanosoma brucei in mice and the efficacy of chemotherapyParasitology, 1977
- Clinical trials of diamidine in Rhodesian sleeping sicknessTransactions of the Royal Society of Tropical Medicine and Hygiene, 1973
- Mehrkernige Thiophene, VIII1) Trypanocide Diamidine des 2‐Phenyl‐thionaphthensEuropean Journal of Organic Chemistry, 1970